Buprenorphine transdermal skin patch and Nuwiq recombinant
Determining the interaction of Buprenorphine transdermal skin patch and Nuwiq recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-NuZole
- Buprenorphine transdermal skin patch-Nuzyra
- Buprenorphine transdermal skin patch-Nuzyra (Omadacycline Injection)
- Buprenorphine transdermal skin patch-Nuzyra (Omadacycline Tablets)
- Buprenorphine transdermal skin patch-Nuzyra Intravenous
- Buprenorphine transdermal skin patch-Nuzyra oral/injection
- Nuwiq recombinant-Buprenorphine, Buprenorphine Hydrochloride
- Nuwiq recombinant-Buprenorphine/naloxone Oromucosal, Sublingual
- Nuwiq recombinant-Buproban
- Nuwiq recombinant-Bupropion
- Nuwiq recombinant-Bupropion and naltrexone
- Nuwiq recombinant-Bupropion Extended-Release Tablets